Artificial Intelligence and Data Analytics
Quantum Computing in Pharma: Current Developments
Quantum computing holds transformative potential for areas in life sciences beyond drug discovery – we explore its impact so far
Artificial Intelligence: Highlights in Diagnostics
Artificial Intelligence has made tremendous progress, with established applications in diagnostics. We look at these, and areas for future improvement.
Computational Modelling in the Fight Against COVID-19: The Importance of Population Studies
Computational modelling continues to support the fight against COVID-19, with population studies that identify and predict important trends.
Evaluating the Impact of In Silico Modelling: Drug Development and Clinical Research
In silico models are becoming increasingly popular not only in drug discovery, but across clinical research.
How Important is Social Media in Drug Development? Understanding Social Media Mining
Social media mining is one of the ways pharma companies hope to identify key patient population data to support drug development.
The Latest AI Innovations in Clinical Research
The latest news demonstrates the potential impact of AI technologies in research and development and clinical trials.
The Emerging Technology of Brain-Computer Interfaces In Clinical Research
Emerging brain computer interface technology offers hope for paralysis patients, with recent advancements progressing to clinical trials.
How In Silico Modelling is Changing Our Approach to Drug Development and Clinical Research
In silico computer models can evaluate new treatments and test conditions. Their ability to model human diseases could have great promise.
DeepMind’s AI Predicts Structures for More Than 350,000 Proteins
DeepMind’s AI system has unlocked the 3D structure of more than 350,000 proteins -but what does this mean for therapeutic advancements?
How can AI accelerate pharmaceutical manufacturing?
The integration of AI within pharma manufacturing is slowly increasing, to potentially help keep up with demand on a shorter time scale.
NVIDIA Launches Supercomputer to Aid UK Healthcare
NVIDIA has launched its latest supercomputer. Cambridge-1 has the potential to improve all aspects of life science and pharma research.
Synthetic Biology: What Does it Mean for the Pharma Industry?
The synthetic biology industry is expected to jump from $9.5 billion to $30.7 billion in 2021 – we look at the opportunities and challenges.